Adélaïde Charlier OA - Liste vers Sélection d’auteur(e)s 2024 ENMicroplastics and Nanoplastics in Atheromas and Cardiovascular Events - NEJMMicroplastics and nanoplastics (MNPs) are emerging as a potential risk factor for cardiovascular disease in preclinical studies. Direct evidence that this risk extends to humans is lacking. Afficher plus.. Voici le lien vers cette page
2024 ENMicroplastics and Nanoplastics in Atheromas and Cardiovascular Events - NEJMMicroplastics and nanoplastics (MNPs) are emerging as a potential risk factor for cardiovascular disease in preclinical studies. Direct evidence that this risk extends to humans is lacking.
2024 ENMicroplastics and Nanoplastics in Atheromas and Cardiovascular Events - NEJMMicroplastics and nanoplastics (MNPs) are emerging as a potential risk factor for cardiovascular disease in preclinical studies. Direct evidence that this risk extends to humans is lacking.